BPOM registration for traditional medicine in Indonesia

Traditional medicine products — jamu, herbal preparations, and standardized herbal medicines — sold in Indonesia need a BPOM registration number before they can be distributed. This category covers products made from natural ingredients used for traditional or herbal health purposes, reviewed by BPOM for safety, consistent quality, and accurate labeling of ingredients and traditional use claims.

Local vs. import registration numbers

Traditional medicine registration numbers use the TR/TI prefix system. TR numbers are assigned to traditional medicine products manufactured domestically in Indonesia. TI numbers are assigned to imported traditional medicine products. The prefix reflects manufacturing origin and drives which manufacturer documentation — local production licensing versus free sale certificate and overseas manufacturing evidence — is required for the dossier.

Typical timeline

Traditional Medicine registration is typically 3–6 months, not guaranteed, once a complete dossier is submitted. Actual timelines depend on BPOM's current review queue and whether the submission needs revision — treat this as a typical range, not a commitment.

Documents needed

Traditional medicine dossiers document the full ingredient composition and manufacturing process. Typical requirements include:

• Product formula and composition, listing all natural ingredients and their proportions
• Label artwork showing product name, ingredients, traditional use description, and usage instructions
• Manufacturer credentials — local production licensing (CPOTB) for domestic manufacturers, or a free sale certificate and manufacturing evidence for imports
• Company documents for the registration holder, including business license and, for imports, appointment as local representative

Traditional medicine review pays particular attention to ingredient consistency and any restricted or regulated natural substances, since formulas in this category can vary batch to batch more than synthetic products if manufacturing controls are not well documented. Demonstrating a stable, repeatable formulation and sourcing process is often what separates a straightforward review from one that draws follow-up questions from BPOM.

Frequently asked questions